Charles Cherington 13D and 13G filings for Ernexa Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:26 pm Purchase | 2026-02-10 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 10,791,335 34.700% | 10,791,335 (New Position) | Filing |